CVS Health Corp
(BSP:CVSH34)
R$
31.75
-0.09 (-0.28%)
Market Cap: 403.33 Bil
Enterprise Value: 794.75 Bil
PE Ratio: 9.69
PB Ratio: 0.92
GF Score: 76/100 CVS Health Corp at Credit Suisse Healthcare Conference Transcript
Nov 09, 2022 / 04:35PM GMT
Release Date Price:
R$51.53
(-1.39%)
Albert J. William Rice;dit Suisse AG
CrÃ;Research Division - Research Analyst
© -
Hello, everyone. I'm A.J. Rice, the health care services analyst at Credit Suisse. We're very pleased to have up next in the room, CVS Health; and Shawn Guertin, the Chief Financial Officer, is with us today.
Questions & Answers
Albert J. William Rice;dit Suisse AG
CrÃ;Research Division - Research Analyst
© -
Let me just sort of kick it off with an open any question. If you think about this year, Shawn, we're on our 11th month, spent a lot of things that have developed and transpired. But what would you sort of highlight is some of the wins for CVS and maybe some of the challenges?
Shawn Michael Guertin
CVS Health Corporation - Executive VP & CFO
Yes. I think from a big picture perspective, what I'd say really the year has been extremely successful, especially it pertains to '22 and I'll talk a little bit more about it. But if there were a few clouds that popped up, they
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot